- Stem cell banking involves the collection, processing, and storage of stem cells for potential future use in regenerative medicine and treatment of various diseases. It plays a vital role in personalized medicine, especially for conditions such as leukemia, lymphoma, and certain genetic disorders
- The growing demand is largely driven by increasing awareness of the therapeutic potential of stem cells, a rising number of clinical trials, and the expanding scope of regenerative medicine
- North America is expected to dominate the global stem cell banking market with largest market share of 43.90%, due to the presence of established biobanking infrastructure, advanced healthcare systems, and supportive government and private investments in stem cell research
- Asia-Pacific is expected to be the fastest growing region in the stem cell banking market during the forecast period due to growing awareness, improving healthcare infrastructure, and increasing birth rates, particularly in countries like India and China
- Regenerative medicine segment is expected to dominate the market with a largest market share of 85.63% due to the significant therapeutic potential of stem cells in treating a wide array of diseases, including cancer, cardiovascular conditions, and neurological disorders. Advancements in regenerative medicine have led to the development of novel therapies, such as CAR-T cell-based treatments, which have shown promising results in clinical applications
